Brendan has spent his career utilizing world class operating principles in the life science and clinical diagnostic industries. The Medicinal Genomics (MGC) team has a finite attention to detail to ensure that MGC can and will produce the finest quality products in the world. This approach has been part of MGCs culture and a strong passion of Brendan’s his entire career. Brendan has had the opportunity to work with incredibly bright scientists, entrepreneurs and business professionals while building Agencourt Bioscience, Agencourt Personal Genomics, Courtagen Life Sciences and Medicinal Genomics.
Brendan holds a BS in Management Science from Muhlenberg College and an MBA from Rensselaer’s Lally School of Management and Technology. While at Rensselaer, Brendan received the Delmar W. Karger Award in Management for outstanding academic and leadership achievements. In 2006 Brendan was named the William F. Glaser ’53 Rensselaer Entrepreneur of the Year. Brendan is also a board member of the Avon Old Farms School where he serves as Co-Vice Chairman and Treasurer. In addition, Brendan is a member of Boston Harbor Angels and an advisor to Rensselaer’s Lally School of Management and Technology. When not not pushing for lean manufacturing concepts, Brendan enjoys boating and martial arts.
CSO & Founder
Kevin has spent his career researching and developing various DNA sequencing technologies in both the research and clinical industries. Additionally Kevin has had a parallel interest in driving the tools used for personalized medicine into the world of cannabis medicine. Kevin believes the intersection of personalized medicine, genomics, blockchains and cannabis is one of the most exciting growth opportunities in our lifetime. Kevin is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment (Kannapedia.net) for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics. Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and held the position of Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLiD sequencing technology. Integral to the SOLiD R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next generation sequencing and saw particular excitement and traction in human tumor sequencing. Kevin initiated an R&D project to investigate chemFET semiconductor based DNA sequencing and spearheaded a process to acquire the DNA sequencing company Ion Torrent for $350M. These collaborations resulted in hundreds of publications and 7 Journal covers from Science Translational Medicine to Nature.
Kevin was the President and CSO of Agencourt Personal Genomics, a startup company he co-founded in 2005 to invent revolutionary sequencing technologies that dropped the cost of sequencing a human genome from $300M to $3,000; a 100,000-fold improvement in sequencing speed and cost in a few years. Kevin oversaw the growth and research of APG until it was sold it to Applied BioSystems. In 2000, Kevin Co-Founded Agencourt Biosciences Corporation and acted as the CSO until 2005 where it was acquired by Beckman Coulter. From 1996 to 2000 Kevin managed the Research and Development for the Human Genome Project at Whitehead Institute/MIT resulting in several patents for nucleic acid purification. Kevin holds a B.S. in Biology from Emory University with a focus on cloning and expressing Norepinephrine Transporters. When not decoding DNA and unraveling the mysteries of cannabis medicine, Kevin enjoy boating, skiing, and gardening.
Vice President, Human Resources
Elizabeth has long been an advocate of cannabis legalization, cannabis genetics and safety and is proud to be part of a team of people who are bringing state-of-the-art technology to cannabis plant genetics.
Elizabeth has over 20 years of experience in the role of Human Resource Business Partner. Elizabeth has been the human resource lead in several mergers, acquisitions and divestures. She has worked in the biotechnology industry since 1996 with with drug discovery, genomics, and medical device companies. Elizabeth graduated from Northeastern University and holds her Senior Professional Human Resources Certification (SPHR). She is a member of Northeast Human Resources Association (NEHRA) and the Society of Human Resource Management (SHRM). Elizabeth was a Chair at the Massachusetts Biotechnology Company for ten years and is one of the founders of HRBiotech Connect, a group formed in 2006 to provide a forum for senior level human resource business partners to debate and discuss current issues. Elizabeth currently resides in Boulder, Colorado and travels to the east coast on a regular basis.
Vice President, Operations
Tim has spent the last 15 years working in the genomics space alongside many of the MGC team members. Before joining MGC, Tim was Vice President, Customer Support & Logistics for Courtagen Life Sciences, Inc. where he focused on building a world class sequencing laboratory operation and managed all aspects of order management and customer support.
Tim worked for Agencourt Bioscience from its 2001 inception through its acquisition by Beckman Coulter in 2006, leaving in 2007 to pursue an MBA. Throughout Agencourt’s rapid growth, Tim worked in manufacturing services. His responsibilities included purchasing, inventory planning and control, quality management, facilities management, and new product development. Most notably Tim led a task force that implemented lean manufacturing practices in the laboratory, maintaining a low cost structure to drive margins and other key indicators. Tim applied these same skills and had similar responsibilities at Courtagen. Tim also served on the New Product Development committee at Agencourt as well as at Courtagen and managed the release of several successful product launches at both companies.
Tim earned his undergraduate degree in Business/Finance at the University of Colorado at Boulder. He left Agencourt in 2007, a year after the merger with Beckman Coulter, to pursue an MBA at Babson College. While studying at the F.W. Olin Graduate School of Business at Babson College he worked as an intern for the Boston Harbor Angel group coordinating deal screening and due diligence activities. Tim graduated from Babson in June of 2009. When out of the office Tim can usually be found enjoying the outdoors with his wife and two kids, most often golfing or skiing.
Executive Sales Advisor
Mr. Suh has over 20 years of technical, business and strategy experience in the field of DNA sequencing. He started his career in the lab and became Team Leader of a production sequencing group at The Institute for Genomic Research founded by Dr. Craig Venter. From the lab, Mr. Suh migrated to the biotechnology industry and has been involved with several successful start-up companies. He’s partnered with the founding teams of Agencourt Bioscience and Kapa Biosystems to set up and execute their commercial strategies by focusing on strategic marketing, talent acquisition and establishing key relationships with customers and opinion leaders. Mr. Suh also drove the sales efforts and helped to create a customer centric culture. Agencourt and Kapa were acquired by Beckman Coulter and Hoffmann La Roche respectively and Mr. Suh remained for the post-merger integrations. Mr. Suh has a B.S. in Biology from Siena College and completed the Greater Boston Executive Program at MIT Sloan School of Management.
Director, CannMed Events
Doug joined Medicinal Genomics at the onset of co-founding CannMed Events in 2016. Previously Doug worked at Courtagen Life Sciences team as Director, Non-Profit and Volunteer Outreach. Doug has more than twenty years of experience in providing humanitarian aid in impoverished regions around the world. His work in Honolulu included developing the New Hope Relief program and leading more than 200 medical, first response, and community development outreach programs in Southeast Asia and the South Pacific. Following the Indian Ocean tsunami in 2004, his relief efforts included working as a producer on the film “The Third Wave”, which was screened in the first ever Presidential Jury Screening in the 2008 Cannes Film Festival and resulted in the development of CTEC – a community based tsunami warning center in Peraliya, Sri Lanka.
In 2009, he joined the staff of the Happy Hearts Fund as the Director of Volunteers where he developed multiple platforms for individuals and groups to participate in providing second wave response efforts following natural disasters including, nationwide fundraising teams to benefit the construction of schools, a New York City based intern program that played an active role with the Clinton Global Initiative, an online education program to equip students around the world in response to natural disasters, and traveled extensively to impacted regions for the purpose of nurturing the relationship between HHF and donors.
He currently resides in New York and Honolulu and continues as a consultant for non-profit organizations in volunteer development. At the core of all he does is his goal to see people realize the joy found when they apply their skills and passions to meet the needs of others.
Sr. Applications Scientist
Heather joined the Medicinal Genomics team in 2015 to provide technical support to both R&D and customers. Previously Heather was an Application Scientist supporting reagents and automation for Courtagen Life Sciences, Perkin Elmer and Beckman Coulter. Heather began her career at the bench making DNA libraries which contributed to the sequencing of chromosome 10 of the Human Genome Project at Genome Therapeutics. GTC was acquired by Agencourt Bioscience in 2003. Heather continued to work with the Agencourt team through the Beckman Coulter acquisition as she transitioned into Project Management and technical customer support and training. Heather is a graduate of Florida Atlantic University where she earned her Bachelor’s degree in Biology.
Yvonne and has been a key member of the R&D team that has produced high quality products for Medicinal Genomics. Previously to MGC, Yvonne worked at Courtagen Life Sciences and was instrumental in the development of several clinically actionable assays. Prior to joining Courtagen, she was a Senior Development Scientist at Beckman Coulter Genomics (formerly Agencourt Bioscience). While there she was part of a team that developed and validated The Agencourt Genfind™ v2 gDNA Isolation Kit and Viral Nucleic Extraction Kit. She was also a key member of the Molecular Diagnostics Research and Development team.
Yvonne was also a Senior Laboratory Technician at The Center of Human Genetics at Boston University School of Medicine. There she performed over a half a million genotype experiments on samples from more than three thousand patients. She also built the laboratory’s mass spectrometry program for single nucleotide polymorphism detection, and she was responsible for all such experiments conducted in the lab.
Yvonne received her Bachelor’s degree in Biology from Syracuse University and Master’s degree in Biochemistry from Boston University School of Medicine.
Ben joined the MGC team in 2016 and enjoys the challenge of trying to simplify the science of MGC for the layman. Ben also maintains Kannapedia.net and helps to organize and execute MGCs annual CannMed Conference. Previously Ben worked with Barton Associates where he gained experience in digital marketing, lead generation, social media, design, and content creation. Earlier in his career Ben worked at HCPro and was the editor of a healthcare coding and billing newsletter. Ben received his Bachelor of Journalism from University of New Hampshire. When not working Ben enjoys running, playing soccer, supporting New England sports team and spending time with family.
Kate has spent over twelve years working in various accounting and tax roles in both public and private corporations. Most recently Kate was employed at Courtagen Life Sciences in the position of Senior Accountant before joining MGC as Controller. Kate received a BS in Marketing and MSA from Bentley University. In her spare time, Kate enjoys traveling volunteering and knitting.
Senior Sales Representative
Zac has worked in the clinical diagnostics space for the last six years, most recently as Clinical Field Specialist at Color Genomics. Zac is a long time cannabis grower, enthusiast and legalization supporter, joining the MGC team to utilize his knowledge of genetics and passion for cannabis to help ensure safe, quality products for both the medical and recreational markets. Zac graduated with a BA from Arizona State University. Zac resides in Rhode Island with is wife and 2 children.
Kyle Boyar is a cannabis scientist with a background in neurobiology and analytical chemistry who has been working in the industry for five years. Kyle received his Bachelor’s degree in Neuroscience from the University of California Santa Cruz and was previously employed as a Laboratory Manager for SC Laboratories. In addition to his work with Medicinal Genomics he also serves as the Social Media Coordinator for the American Chemical Society’s Cannabis Chemistry Subdivision.
Customer Support Specialist
Blair has spent his career in customer service and inside sales. Previous to joining MGC, Blair worked at Courtagen Life Sciences in the position of Patient Advocate, and before that he spent 15 years running a small manufacturing company in the pewter giftware industry. Blair received his BA from Rollins College and Masters of Fine Arts from University Wisconsin-Maidson.